Credit: Getty Images. Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease. Although the majority of congenital heart diseases (CHD) are ...
Nasdaq: Merit Medical Systems Initiates PREEMIE Study on Bloom Micro Occluder System for Treating Patent Ductus Arteriosus in Premature Infants Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ... Merit Medical Systems Initiates PREEMIE Study on Bloom Micro Occluder System for Treating Patent Ductus Arteriosus in Premature Infants MedPage Today: Preterm Infants Treated Early for Patent Ductus Arteriosus Had Worse Outcomes Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.
surgery for patent ductus arteriosus, The New England Journal of Medicine: A Surgical Approach for Ligation of a Patent Ductus Arteriosus The New England Journal of Medicine: Trial of Selective Early Treatment of Patent Ductus Arteriosus with Ibuprofen The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with ibuprofen would improve short-term ... EurekAlert!: Expectant management vs medication for patent ductus arteriosus in preterm infants About The Study: In extremely preterm infants with a protocol-defined patent ductus arteriosus, death or bronchopulmonary dysplasia did not differ between the expectant management group and the active ... The multicentre, randomised, double-blind, placebo-controlled Baby-OSCAR trial. Participants were 653 extremely preterm infants with a large patent ductus arteriosus (diameter, ≥ 1.5 mm).
surgery for patent ductus arteriosus, In the first ...
